Baudax Bio, Inc. Profile Avatar - Palmy Investing

Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-N…

Biotechnology
US, Malvern [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of BXRX's Analysis
CIK: 1780097 CUSIP: 07160F206 ISIN: US07160F4046 LEI: - UEI: -
Secondary Listings
BXRX has no secondary listings inside our databases.